Age-associated changes in the expression pattern of cyclooxygenase-2 and related apoptotic markers in the cancer susceptible region of rat prostate

Authors:
  • YLYingying Liu
    Yingying Liu
  • MEMazen B. Eldeen
    Mazen B. Eldeen
  • WMWillard Morrow
    Willard Morrow
  • ZRZaineb R. Razak
    Zaineb R. Razak
  • MMMarie Maradeo
    Marie Maradeo
  • MBMostafa Z. Badr
    Mostafa Z. Badr

Abstract
Senescence-associated changes in the prostate are believed to play an important role in the genesis of prostate cancer. In order to provide further information on how aging increases the prostate susceptibility to cancer, we examined the pattern of cyclooxygenase (COX)-2 expression and the concomitant alterations in prostaglandin E 2 (PGE 2 ) synthesis in the prostate glands of 4-, 10-, 50- and 100-week-old Fischer 344 rats. This was carried out in the prostatic areas where hormone-induced tumors arise, namely the periurethral ducts of the dorsolateral prostate (DLP). Age-associated changes were also evaluated for pro- and anti-apoptotic factors linked to COX-2 signaling and known to be involved in the normal development of the prostate gland as well as in carcinogenesis. COX-2 expression was increased in the DLP in an age-dependent manner where senescent rats had >3–4-fold higher COX-2 mRNA and protein levels than their juvenile counterparts ( P 2 synthesis. Evaluation of mediators of apoptotic signaling showed a significant ( P 6-fold) and peroxisome proliferator-activated receptor γ (>3-fold) and in caspase-3 activity (>2-fold) and an up-regulation of the anti-apoptotic Bcl 2 (>8-fold), PKCα (>2-fold) and pAkt (>4-fold) in the 100-week-old rats versus the 4-week-old animals. There was an ∼15-fold age-dependent decrease in the pro-apoptotic ratio BAX:Bcl 2 and an increase in the anti-apoptotic variable PKCα * Bcl 2 /BAX in the senescent rats compared with the juvenile ones. These results suggest that increased COX-2 expression can be linked to the decline in the pro-apoptotic signaling in the prostate gland during aging. Subsequently, COX-2 inhibitors can be considered as a promising class of agents to attenuate the increased cell survival and, hence, protect against tumorigenesis in the aging prostate.